Ezetimibe — brands & medicines in Pakistan
Pakistan mein Ezetimibe ke 1 brands available hain. Drug class: Cholesterol Absorption Inhibitor. Neeche se koi bhi brand select karein aur uses, dosage, side effects aur price dekhein.
Quick Answer
Ezetimibe is a cholesterol absorption inhibitor used in Pakistan for Hypercholesterolaemia — high cholesterol, Homozygous familial hypercholesterolaemia (HoFH — combination therapy), Homozygous sitosterolaemia (phytosterolaemia — plant sterol absorption disorder). Available as 1 brand. Prescription required. Always confirm dose with a doctor or pharmacist.
What is Ezetimibe?
Ezetimibe is a cholesterol absorption inhibitor used in Pakistan for a range of medical conditions. Doctors and pharmacists in Pakistan recognize Ezetimibe under multiple brand names — currently 1 listed on PakVita (1 tablet). The information below is a synthesis from DRAP-registered medicine entries, BNF, and WHO Essential Medicines references.
Common indications
- Hypercholesterolaemia — high cholesterol
- Homozygous familial hypercholesterolaemia (HoFH — combination therapy)
- Homozygous sitosterolaemia (phytosterolaemia — plant sterol absorption disorder)
Indication and dose vary by medical condition, age, weight, and other factors. Always confirm with a qualified doctor or pharmacist before starting.
Typical dosage
As prescribed
This is a general adult guidance pattern based on the manufacturer's label for one of the Ezetimibe brands listed below. Children, elderly patients, pregnant women, and people with kidney or liver impairment usually need different dosing — confirm with your doctor.
Side effects
Common (usually mild)
- Mild GI disturbance
- Upper respiratory tract infection (nazla zukam)
- Arthralgia
- Headache
Serious — stop and see a doctor
- Myopathy / rhabdomyolysis
- Hepatitis / liver toxicity (rare — LFT abnormalities)
- Hypersensitivity reactions (rare — rash, angioedema)
Important warnings
- Monitor liver function tests (LFTs) especially when used with a statin
- Report muscle pain immediately — myopathy and rhabdomyolysis are possible
- Do not use in severe hepatic impairment
- Ezetimibe exposure is significantly increased with cyclosporin — dose adjustment is required
Ezetimibe brands in Pakistan (1)
Click any brand to see full uses, dosage, side effects, prices, and warnings.
Frequently asked questions
What is Ezetimibe used for in Pakistan?
Ezetimibe is commonly used for Hypercholesterolaemia — high cholesterol, Homozygous familial hypercholesterolaemia (HoFH — combination therapy), Homozygous sitosterolaemia (phytosterolaemia — plant sterol absorption disorder). It belongs to the cholesterol absorption inhibitor drug class.
What is the typical dosage of Ezetimibe?
Typical adult dosing is described by manufacturers as: "As prescribed". Always confirm dose, duration, and timing with a qualified doctor or pharmacist — dose depends on indication, weight, age, kidney/liver function, and other medications.
What are the common side effects of Ezetimibe?
Common side effects include Mild GI disturbance, Upper respiratory tract infection (nazla zukam), Arthralgia, Headache. Most are mild and resolve as the body adjusts. Stop the medicine and contact a doctor if side effects are severe, persistent, or include allergic symptoms (rash, swelling, breathing difficulty).
When should I stop Ezetimibe and see a doctor?
Stop Ezetimibe and seek urgent medical care if you experience: Myopathy / rhabdomyolysis; Hepatitis / liver toxicity (rare — LFT abnormalities); Hypersensitivity reactions (rare — rash, angioedema). These are serious signs that need immediate attention.
Is Ezetimibe available without a prescription in Pakistan?
Prescription required.
What brands of Ezetimibe are available in Pakistan?
1 brand of Ezetimibe is listed on PakVita: 1 tablet. Browse the brand list below and click any name for prices, dosage, and full information.
Sources
- DRAP Registered Drug Products Database — Drug Regulatory Authority of Pakistan
- British National Formulary (BNF) — BMJ Group & Pharmaceutical Press
- WHO Model List of Essential Medicines, 23rd ed. — World Health Organization